However, only CD8+ cells were significantly higher in SHD-RT-treated tumors than in other groups (Figure 2), even though the SHD-RT- and F-RT-treated tumors were of similar tumor mass (Figure 1). This evidence concerns the gene CD8A and neoplasm.